Alternatives to Algorithmiq

Developing advanced quantum computing algorithms and software for complex problem-solving.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Quantum computing application and algorithm development

Q-ANT is a startup developing advanced quantum computing solutions for complex problem-solving.

Quantum compression technology for complex simulations, extending hardware capabilities.

Pasqal develops quantum computing solutions for complex scientific and industrial problems.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Finnish quantum computer manufacturer building fault-tolerant quantum computers for various industries.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

IonQ is a leader in quantum computing, developing powerful quantum computers for various industries.

A global leader in clinical pharmacology and bioanalytical sciences.

Building the world's first scientific superintelligence platform and autonomous labs.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Quantum Kinetics is developing quantum computing solutions for complex scientific and industrial problems.

Pioneering vision restoration therapies for severe retinal degenerations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Builds the Quantum Orchestration Platform (QOP) to accelerate quantum computing development and deployment.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Developing practical photonic quantum computers using a novel photon-atom gate architecture.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Quantum computing software platform for designing and optimizing quantum circuits.

Designs and manufactures advanced cryogenic I/O infrastructure for quantum computers.

AI-powered platform accelerating biological research and drug discovery.

Quantum computing software company developing tools for fault-tolerant quantum computers.

Israeli startup developing quantum noise resilience software to improve quantum computing.

Quantum computing startup developing a quantum processor and software stack.

Xanadu is a Canadian quantum computing company building photonic quantum computers and developing quantum software.

Physics-based software platform for molecular discovery and design in life and materials sciences.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Riverlane develops quantum error correction technology to make quantum computers useful sooner.

Develops a computational model of the human body for drug discovery and development.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

AI-powered platform for understanding disease biology and accelerating drug discovery.

A public benefit company focused on quantum-safe security and AI.

AI-guided drug discovery platform for tissue-targeted medicines.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Software infrastructure that unifies classical CPUs/GPUs with quantum processors for distributed hybrid quantum-classical computing.

AI-powered research assistant for scientific literature review and data extraction.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.